In independent tests RGF PHI Cell technology was shown to have a 99.9% inactivation rate on surface and 99.5% inactivation rate on aerosol forms of the SARS-CoV-2 (COVID19) virus.
Testing commenced in March carried out in a 36m3 (1,280ft3) testing chamber using the SARS-CoV-2 virus, not a surrogate or similar virus. Results show the virus is killed on contact with the PHI’s cleaning agents, effectively neutralising the virus within the chamber within a matter of minutes.
It is important to note that no medical claims are made.